14.09.2015
- As a first step toward doubling its manufacturing and production capacity for biologics in the US, AstraZeneca has acquired a high-tech biologics bulk manufacturing facility in...
10.09.2015
- UK drug cost-effectiveness agency National Institute for Health and Care Excellence, NICE, has approved the use of US drugmaker Merck’s Keytruda for treatment of certain cases of...
09.09.2015
- Australia’s Starpharma has signed a licensing agreement with AstraZeneca, giving the Anglo-Swedish company commercialization rights for oncology compounds directed at a defined...
04.09.2015
- Canadian drugmaker Valeant has said it will work with AstraZeneca on a potential treatment for psoriasis, brodalumab, taking up the gauntlet from Amgen, which recently curtailed...
29.07.2015
- French pharmaceutical producer Sanofi and its subsidiary Genzyme have agreed to acquire the Caprelsa (vandetanib) rare disease therapy of British-Swedish drugmaker AstraZeneca...
22.07.2015
- US drugmaker Pfizer has more collaborations with British universities than any other foreign company, according to the newly published Dowling Review conducted by Ann Dowling...
17.07.2015
- US biotech firm Celgene has agreed to pay $7.2 billion, or $232 per share, to acquire compatriot Receptos, a biotech company that makes a potential blockbuster drug to treat...
13.07.2015
- In another move to sharpen its focus on oncology, diabetes and respiratory disorders, AstraZeneca has announced it is selling all non-US rights for Entocort, a treatment for Crohn...
